Combination of serum 5-S-cysteinyldopa, melanoma inhibitory activity and IL-8 improves the diagnostic accuracy of malignant melanoma compared with individual markers

Early diagnosis of malignant melanoma is critical for effective treatment and reduced patient mortality. However, current clinical and histological variables show limited accuracy in diagnosis. Serum or urine level of 5-S-cysteinyldopa (5-S-CD) is a commonly used melanoma biomarker in Japan owing to...

Descripción completa

Detalles Bibliográficos
Autores principales: Katoh, Yuki, Hara, Hiroyuki, Harada, Tomonori, Hirai, Shuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439753/
https://www.ncbi.nlm.nih.gov/pubmed/36107519
http://dx.doi.org/10.1097/MD.0000000000030471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439753/
https://www.ncbi.nlm.nih.gov/pubmed/36107519
http://dx.doi.org/10.1097/MD.0000000000030471

Ejemplares similares